These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8027672)

  • 21. Up-regulation of human eosinophil leukotriene C4 generation through contact with bronchial epithelial cells.
    Dent G; Rühlmann E; Bodtke K; Magnussen H; Rabe KF
    Inflamm Res; 2000 May; 49(5):236-9. PubMed ID: 10893047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitory effect of ONO-1078, a novel leukotriene receptor antagonist, on human peripheral blood eosinophils].
    Kobayashi S; Yoshida K; Mori A; Sugiyama H; Suko M; Okudaira H; Ito K; Inokuma S; Matsumura Y
    Arerugi; 1996 Nov; 45(11):1166-71. PubMed ID: 8990528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils].
    Kawashima T; Nagaki S; Iwakaji A; Iwamoto I; Yoshida S; Tomioka H
    Arerugi; 1994 Dec; 43(11):1326-30. PubMed ID: 7887808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils.
    Sano A; Muñoz NM; Sano H; Choi J; Zhu X; Jacobs B; Leff AR
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1903-9. PubMed ID: 10351938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.
    Fitzharris P; Moqbel R; Thorne KJ; Richardson BA; Hartnell A; Cromwell O; Butterworth AE; Kay AB
    Clin Exp Immunol; 1986 Dec; 66(3):673-80. PubMed ID: 3568455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists.
    Takafuji S; Bischoff SC; De Weck AL; Dahinden CA
    J Immunol; 1991 Dec; 147(11):3855-61. PubMed ID: 1940371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytosolic phospholipase A2, increased and activated in the eosinophils of patients with hypereosinophilic syndrome in vivo, is involved in the augmented release of leukotriene C4.
    Urasaki T; Ninomiya H; Takasaki J; Kawauchi Y; Nagasawa T; Masuho Y
    Inflamm Res; 1999 Jan; 48(1):36-40. PubMed ID: 9987681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.
    Weller PF; Lee CW; Foster DW; Corey EJ; Austen KF; Lewis RA
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7626-30. PubMed ID: 6324182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular communication in leukotriene C4 production between eosinophils and neutrophils.
    Kloprogge E; de Leeuw AJ; de Monchy JG; Kauffman HF
    Int Arch Allergy Appl Immunol; 1989; 90(1):20-3. PubMed ID: 2509375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of arachidonic acid generation in human basophils: relationship between the effects of inhibitors of secretory phospholipase A2 activity and leukotriene C4 release.
    Hundley TR; Marshall LA; Hubbard WC; MacGlashan DW
    J Pharmacol Exp Ther; 1998 Mar; 284(3):847-57. PubMed ID: 9495842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.
    Miura K; Schroeder JT; Hubbard WC; MacGlashan DW
    J Immunol; 1999 Apr; 162(7):4198-206. PubMed ID: 10201947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of fibronectin on the production of leukotriene C4 by eosinophils.
    Yoshida K; Suko M; Matsuzaki G; Sugiyama H; Okudaira H; Ito K
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():50-1. PubMed ID: 7549524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential generation of leukotriene C4 by human eosinophils.
    Shaw RJ; Cromwell O; Kay AB
    Clin Exp Immunol; 1984 Jun; 56(3):716-22. PubMed ID: 6086189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of leukotriene C4 from human eosinophils and its relation to the cell density.
    Kajita T; Yui Y; Mita H; Taniguchi N; Saito H; Mishima T; Shida T
    Int Arch Allergy Appl Immunol; 1985; 78(4):406-10. PubMed ID: 3934084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adhesion-dependent interactions between eosinophils and cholinergic nerves.
    Kingham PJ; McLean WG; Sawatzky DA; Walsh MT; Costello RW
    Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1229-38. PubMed ID: 12003778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased generation of leukotriene C4 from eosinophils in asthmatic patients.
    Taniguchi N; Mita H; Saito H; Yui Y; Kajita T; Shida T
    Allergy; 1985 Nov; 40(8):571-3. PubMed ID: 3937459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposing effects of tumor necrosis factor-alpha and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine.
    Takafuji S; Bischoff SC; De Weck AL; Dahinden CA
    Eur J Immunol; 1992 Apr; 22(4):969-74. PubMed ID: 1551409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo effect of prednisolone on release of leukotriene C4 in eosinophils obtained from asthmatic patients.
    Shindo K; Hirai Y; Koide K; Sumitomo M; Fukumura M
    Biochem Biophys Res Commun; 1995 Sep; 214(3):869-74. PubMed ID: 7575557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils.
    Lam BK; Owen WF; Austen KF; Soberman RJ
    J Biol Chem; 1989 Aug; 264(22):12885-9. PubMed ID: 2753893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin.
    Mesquita-Santos FP; Vieira-de-Abreu A; Calheiros AS; Figueiredo IH; Castro-Faria-Neto HC; Weller PF; Bozza PT; Diaz BL; Bandeira-Melo C
    J Immunol; 2006 Feb; 176(3):1326-30. PubMed ID: 16424158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.